Ligand · L4V
L4V · 13-Chloro-14,16-dihydroxy-2-methyl-2,3,4,5,9,10-hexahydrobenz[c][1]azacyclotetradecine-1,11(8H,12H)-dione
L4V, 13-Chloro-14,16-dihydroxy-2-methyl-2,3,4,5,9,10-hexahydrobenz[c][1]azacyclotetradecine-1,11(8H,12H)-dione (C18 H22 Cl N O4, 351.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with…
- Component
- L4V
- Formula
- C18 H22 Cl N O4
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
L4V in 2 structures; the first of them:
- 4CE3 · Hsp90 N-terminal domain bound to macrolactam analogues of radicicol. · L4V A1215 · binds LEU34, ASN37, ALA38, ALA41, LYS44, ASP79, ILE82, GLY83 and 6 more
- 4CE3 · HSP90 N-terminal domain bound to macrolactam analogues of radicicol. · L4V A1215 · binds LEU34, ASN37, ALA38, ALA41, LYS44, ASP79, ILE82, GLY83 and 6 more
Residues it binds most
LEU 2, ALA 2, ASN 2, ASP 2, GLY 2, ILE 2, LYS 2, MET 2, PHE 2, THR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.